Effects of Newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines

International Journal of Molecular Sciences

Volumn 12, Issue 12, 2011, Pages 8645-8660

  Alabsi, Aied M ^a,b,c   Bakar, Siti Aishah Abu ^a   Ali, Rola ^a   Omar, Abdul Rahman ^b   Bejo, Mohd Hair ^b   Ideris, Aini ^b   Ali, Abdul Manaf ^a  

^a UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Apoptosis; Cytolytic; Flow cytometry; Leukemia; NDV

Indexed keywords

ANTINEOPLASTIC AGENT; ARABINOCYTOSINE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; DOXORUBICIN; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOSIS INHIBITION; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; TUMOR CELL DESTRUCTION; VIRUS STRAIN; 3T3 CELL LINE; ANIMAL; BLOOD CELL; FIBROBLAST; HEMOLYSIS; NEWCASTLE DISEASE VIRUS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

3T3 CELLS; ANIMALS; APOPTOSIS; BLOOD CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLASTS; HEMOLYSIS; MICE; NEWCASTLE DISEASE VIRUS;

EID: 84055211819     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12128645     Document Type: Article

References (34)

1. Cotran, R.S.; Kumar, V.; Robbin, S.L. Neoplasia. In Robbin's Pathologyical Basis of Diseases, 5th ed.; Saunders: Philiadelphia, PA, USA, 1994; pp. 241-303, 649-658.
2. Hughes-Jones, N.C.; Wickramasinghe, S.N. Acute and Chronic Leukemia. In Lecture Notes on Haematology, 6th ed.; Blackwell Science Ltd.: Paris, France, 1996; pp. 134-160.
3. Zuco, V.; Rhigetti, S.C.; Cleris, E.; Marchesi, L.; Passerini, C.G.; Formelli, F. Selective cytotoxicity of betulinic acid on tumor cell lines but not normal cells. Cancer Lett. 2002, 175, 17-25.
4. Parato, K.A.; Senger, D.; Forsyth, P.A.J.; Bell, J.C. Recent progress in the battle between oncolytic viruses and tumours. Nature 2005, 5, 965-976.
5. Freeman, A.I.; Zakay-Rones, Z.; Gomori, J.M.; Linetsky, E.; Rasooly, L.; Greenbaum, E.; Rozenman-Yair, S.; Panet, A.; Libson, E.; Irving, C.S.; Galun, E.; Siegal, T. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol. Ther. 2006, 13, 221-228.
6. Schirrmacher, V.; Ahlert, T.; Pröbstle, T.; Steiner, H.H.; Herold-Mende, C.; Gerhards, R.; Hagmüller, E.; Steiner, H.H. Immunization with virus-modified tumor cells. Semin. Oncol. 1998, 25, 677-696.
7. Omar, A.; Aini, I.; Ali, A.; Othman, F.; Yusoff, K.; Abdullah, J.M.; Wali, H.; Zawawi, M.; Meyyappan, N. An overview on the development of Newcastle disease virus as an anti-cancer therapy. Malays. J. Med. Sci. 2003, 10, 4-12.
8. Alexander, D.J. Newcastle Disease. In Newcastle Disease Virus an Avian Paramyxovirus; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1988; pp. 1-22.
9. Yusoff, K.; Tan, W.S.; Lau, C.H.; Ng, B.K.; Ibrahim, A.L. Sequence of the haemagglutinin-neuraminadase gene of the Newcastle disease virus oral vaccine strain V4 (UPM). Avian Pathol. 1996, 25, 837-844.
10. Mosmann, T. Rapid Colorimetric Assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
11. Pujalté, I.; Passagne, I.; Brouillaud, B.; Tréguer, M.; Durand, E.; Ohayon-Courtès, C.; L'Azou1, B. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part. Fibre Toxicol. 2011, 8, 10:1-10:16.
12. Szeberenyi, J.; Fabian, Z.; Torocsik, B.; Kiss, K.; Csatary, L.K. Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells. Am. J. Ther. 2003, 10, 282-288.
13. Reichard, K.W.; Lorence, R.M.; Cascino, C.J.; Peeples, M.E.; Walter, R.J.; Fernando, M.B.; Reyes, H.M.; Greager, J.A. Newcastle disease virus selectively kills human tumor cells. J. Surg. Res. 1992, 52, 448-453.
14. Adams, J. Proteasome inhibition in cancer: Development of PS-341. Semin. Oncol. 2001, 28, 613-619.
15. Zulkifli, M.M.; Ibrahim, R.; Ali, A.M.; Aini, I.; Jaafar, H.; Hilda, S.S.; Alitheen, N.B.; Abdullah, J.M. Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma. Neurol. Res. 2009, 13, 3-10.
16. Othman, F.; Ideris, A.; Motalleb, G.; Eshak, Z.B.; Rahmat, A. Oncolytic effect of newcastle disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh Med. J. 2010, 12, 17-24.
17. Ali, R.; Alabsi, A.M.; Ali, A.M.; Ainideris Omar, A.R.; Yousoff, K. Apoptosis induction and cytolytic effects of newcastle disease virus strain AF2240 on DBTRG.05 mg brain tumor cell line. Int. J. Cancer Res. 2011, 7, 25-35.
18. Ali, R.; Alabsi, A.M.; Ali, A.M.; Ideris, A.; Omar, A.R.; Yusoff, K.; Saif-Ali, R. Cytolytic effects and apoptosis induction of newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line. Neurochem. Res. 2011, 36, 2051-2062.
19. Ruben, R.L.; Neubuer, R.H. Semiautomated colorimeteric assay for in vitro screening of anticancer compounds. Cancer Treat. Rep. 1987, 71, 1141-1149.
20. Strober, W. Trypan Blue Exclusion Test of Cell Viability. In Current Protocols in Immunology; Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, W.M., Strober, W., Eds.; John Wiley and Sons, Inc.: Hoboken, NJ, USA, 2003.
21. Muneesh, T.; Vishva, M.D. Fas and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. Am. Soc. Biochem. Mol. Biol. 1995, 270, 3255-3260.
22. Cohen, G.M.; Sun, X.M.; Snowden, R.T.; Dinsdale, D.; Skilleter, D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 1992, 286, 331-334.
23. Oberhammer, F.; Wilson, J.W.; Dive, C.; Morris, I.D.; Hickman, J.A.; Wakeling, A.E.; Walker, P.R.; Sikorska, M. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 1993, 12, 3679-3684.
24. Gooch, J.L.; Yee, D. Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett. 1999, 144, 31-37.
25. Telford, W.G.; King, L.E.; Fraker, P.J. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J. Immunol. Methods 1994, 172, 1-16.
26. Fried, J.; Perez, A.G.; Clarkson, B.D. Flow cytofluorometric analysis of cell cycle distributions using propidium iodide, Properties of the method and mathematical analysis of the data. J. Cell Biol. 1976, 71, 172-181.
27. Nagata, S. Apoptosis by death factor. Cell 1997, 88, 355-365.
28. Ashkenazi, A.; Dixit, V.M. Death receptors: Signaling and modulation. Science 1998, 281, 1305-1308.
29. Locksley, R.M.; Killeen, N.; Lenardo, M.J. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001, 104, 487-501.
30. Slee, E.A.; Adrain, C.; Martin, S.J. Serial killers: Ordering caspase activation events in apoptosis. Cell Death Differ. 1999, 6, 1067-1074.
31. Srinivasula, S.M.; Ahmad, M.; Fernandes-Alnemri, T.; Alnemri, E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1998, 1, 949-957.
32. Slee, E.A.; Adrian, C.; Martin, S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 2001, 280, 4663-4673.
33. Kuida, K.; Zheng, T.S.; Na, S.Q.; Kuan, C.Y.; Yang, D.; Karasuyama, H.; Rakic, P.; Flavell, R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996, 384, 368-372.
34. Woo, M.; Hakem, R.; Soengas, M.S.; Duncan, G.S.; Shahinian, A.; Kägi, D.; Hakem, A.; McCurrach, M.; Khoo, W.; Kaufman, S.A. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998, 12, 806-819.